Literature DB >> 11272129

The discovery of type 1 diabetes.

E A Gale1.   

Abstract

The etiological heterogeneity of idiopathic diabetes has been recognized for 25 years, and subdivision into type 1 and type 2 diabetes is fundamental to the way we think about the disease. Review of the literature suggests that the concept of type 1 diabetes as an immunemediated disease emerged rapidly over the period from 1974 to 1976 and showed many of the features of a classic paradigm shift. A few key observations triggered recognition and acceptance of the new paradigm, but the necessary context was provided by scientific developments in areas mainly unrelated to diabetes. The disease paradigm established by 1976 is still widely accepted, and its essential features have been modified only in detail by the revolution in molecular biology that has occurred over the intervening period. Notwithstanding, some of the underlying assumptions remain imprecise, unchallenged, or unconfirmed. Appreciation of the historical origin and subsequent evolution of these fundamental concepts could stimulate critical analysis and help prepare the way for a new paradigm.

Entities:  

Mesh:

Year:  2001        PMID: 11272129     DOI: 10.2337/diabetes.50.2.217

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  31 in total

Review 1.  Toxic type 1 diabetes.

Authors:  Mark A Myers; Ian R Mackay; Paul Z Zimmet
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

Review 2.  The case for an autoimmune aetiology of type 1 diabetes.

Authors:  S I Mannering; V Pathiraja; T W H Kay
Journal:  Clin Exp Immunol       Date:  2015-10-21       Impact factor: 4.330

3.  Improved Tol2-mediated enhancer trap identifies weakly expressed genes during liver and β cell development and regeneration in zebrafish.

Authors:  Yadong Zhong; Wei Huang; Jiang Du; Zekun Wang; Jianbo He; Lingfei Luo
Journal:  J Biol Chem       Date:  2018-11-30       Impact factor: 5.157

4.  Spring harvest? Reflections on the rise of type 1 diabetes.

Authors:  E A M Gale
Journal:  Diabetologia       Date:  2005-12       Impact factor: 10.122

5.  Do dogs develop autoimmune diabetes?

Authors:  Edwin A M Gale
Journal:  Diabetologia       Date:  2005-10       Impact factor: 10.122

Review 6.  Latent autoimmune diabetes in adults: a guide for the perplexed.

Authors:  E A M Gale
Journal:  Diabetologia       Date:  2005-11       Impact factor: 10.122

7.  Declassifying diabetes.

Authors:  E A M Gale
Journal:  Diabetologia       Date:  2006-09       Impact factor: 10.122

8.  Lentiviral gene therapy vectors encoding VIP suppressed diabetes-related inflammation and augmented pancreatic beta-cell proliferation.

Authors:  Fulya Erendor; Elif Ozgecan Sahin; Ahter D Sanlioglu; Mustafa Kemal Balci; Thomas S Griffith; Salih Sanlioglu
Journal:  Gene Ther       Date:  2020-07-30       Impact factor: 5.250

Review 9.  CXCL10 activities, biological structure, and source along with its significant role played in pathophysiology of type I diabetes mellitus.

Authors:  Zahra Ahmadi; Mohammad Kazemi Arababadi; Gholamhossin Hassanshahi
Journal:  Inflammation       Date:  2013-04       Impact factor: 4.092

10.  A novel hydroxyfuroic acid compound as an insulin receptor activator. Structure and activity relationship of a prenylindole moiety to insulin receptor activation.

Authors:  Henry J Tsai; Shan-Yen Chou
Journal:  J Biomed Sci       Date:  2009-07-30       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.